Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging

• Status: Completed
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to test the safety of the peptide and antibody and at the same time evaluate the tumor imaging of a two step antibody technique in nuclear imaging.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Radboud University
• Collaborators: Gilead Sciences; Immunomedics, Inc.
• Treatments: Antibodies

Criteria

Inclusion Criteria:

• > 18 years of age

• Histologic or cytologic diagnosis of colorectal cancer

• Karnofsky performance status >70%

Exclusion Criteria:

• Pregnant or lactating women

• Severe anorexia

• Active second primary malignancy

• Chemotherapy or radiotherapy within four weeks of study entry